Lipoprotein(a) levels and time to cardiovascular benefit with alirocumab in patients with recent acute coronary syndrome

Ray, K.K.; Szarek, M.; Bhatt, D.L.; Bittner, V.A.; Fazio, S.; Goodman, S.G.; ... ; Schwartz, G.G. (2025)

Article / Letter to editor

• acute coronary syndromes
• alirocumab
• MACE
• MALE

• All authors: Ray, K.K.; Szarek, M.; Bhatt, D.L.; Bittner, V.A.; Fazio, S.; Goodman, S.G.; Harrington, R.A.; Jukema, W.; White, H.D.; Steg, G.; Schwartz, G.G.
• Date: 2025-11-17
• Journal: Journal of the American College of Cardiology
• Volume: 86
• Issue: 21
• Pages: 2071 - 2076
• DOI: doi:10.1016/j.jacc.2025.08.043